QL
WST icon

Quarry LP’s West Pharmaceutical WST Stock Holding History

Quarry LP’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30
Closed -$7.52K – 2583
2026
Q1 		$7.52K Buy
30
+5
+20% +$1.24K ﹤0.01% 915
2025
Q4 		$6.88K Sell
25
-60
-71% -$16.4K ﹤0.01% 1579
2025
Q3 		$22.3K Sell
85
-355
-81% -$86.3K ﹤0.01% 1335
2025
Q2 		$96.3K Buy
440
+318
+261% +$68K 0.02% 571
2025
Q1 		$27.3K Buy
+122
New +$33.6K 0.01% 1029
2024
Q3 		– Sell
-38
Closed -$12.5K – 2126
2024
Q2 		$12.5K Buy
+38
New +$13.4K ﹤0.01% 1251
2024
Q1 		– Sell
-97
Closed -$34.2K – 1939
2023
Q4 		$34.2K Buy
97
+59
+155% +$20.9K 0.01% 481
2023
Q3 		$14.3K Buy
+38
New +$14.7K ﹤0.01% 800

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quarry LP's WST Position: Q2 2026 in Review

Quarry LP sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 30 shares — an estimated $7.52K sold.

Quarry LP first reported a position in WST in Q3 2023 and held it in 8 quarters. The position peaked at $96.3K in Q2 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Quarry LP reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 30 West Pharmaceutical shares in Q2 2026, an estimated $7.52K.
  • Quarry LP first reported a position in West Pharmaceutical in Q3 2023 and held it in 8 quarters.
  • Quarry LP's West Pharmaceutical position peaked at $96.3K in Q2 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.